However, baicalin treatment attenuated the EIOP-induced increase in protein expression of LC3-II, Beclin-1, and ATG5 in Model+NS group, which indicated that baicalin inhibited autophagy in glaucoma progression (Figure 6a). Here, ATG5 is linked to glaucoma.